Glenmark Pharmaceuticals Inc., USA is voluntarily recalling 11,136 bottles of Bisoprolol Fumarate and Hydrochlorothiazide Tablets (2.5 mg/6.25 mg), a medication used to treat high blood pressure. Testing discovered that reserve samples of the medication contained traces of ezetimibe, a different drug used to treat high cholesterol. This cross-contamination occurred during the manufacturing process. Consumers who have these tablets should contact their healthcare provider or pharmacist regarding their treatment.
The presence of traces of ezetimibe in a blood pressure medication represents a cross-contamination risk, which could lead to unexpected side effects or drug interactions for patients unaware they are consuming an additional active pharmaceutical ingredient.
You have 2 options:
Manufactured by Glenmark Pharmaceuticals Limited, Pithampur, India for Glenmark Pharmaceuticals, Inc., USA.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.